country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-W110138

Copy Link Print Information

Chloroxoquinoline

Chloroxoquinoline is an anticancer agent. Chloroxoquinoline damages the DNA templates of cancer cells, inducing DNA breaks and cell death, and inhibits cell invasion via down-regulating Rho/Rho kinase signaling pathway. Chloroxoquinoline enhances the radiation sensitivity of Lewis lung cancer cells and xenograft tumors in tumor-bearing mouse models but decreases efficacy after long term exposure in rat models by auto-induction effects on CYP1A and CYP3A. Chloroxoquinoline has a broad-spectrum anticancer activity, such as non-small-cell lung carcinoma (NSCLC), breast cancer and gastric cancer.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No.: 23833-97-8
화학식: C₉H₆ClNO
분자량:179.60

보관:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (269 KB)

Chloroxoquinoline Chemical Structure

CAS No.: 23833-97-8

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- Cellular Effect
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

All DNA/RNA Synthesis Isoforms :

All Cytochrome P450 Isoforms :

All ROCK Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
BGC-823	IC₅₀	>10 μM Compound: 11	Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay	[PMID: 30496987]
BGC-823	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human BGC823 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay Cytotoxicity against human BGC823 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay	[PMID: 28757067]
BGC-823	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human BGC823 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human BGC823 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay	[PMID: 28942112]
DLD-1	IC₅₀	>10 μM Compound: 11	Cytotoxicity against human DLD1 cells after 48 hrs by MTT assay Cytotoxicity against human DLD1 cells after 48 hrs by MTT assay	[PMID: 30496987]
HCT-116	IC₅₀	>10 μM Compound: 11	Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay	[PMID: 30496987]
HCT-116	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay	[PMID: 28942112]
HCT-8	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human HCT8 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay Cytotoxicity against human HCT8 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay	[PMID: 28757067]
HCT-8	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human HCT8 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human HCT8 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay	[PMID: 28942112]
HeLa	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay	[PMID: 28757067]
HeLa	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay	[PMID: 28942112]
HEp-2	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human Hep2 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay Cytotoxicity against human Hep2 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay	[PMID: 28757067]
HEp-2	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human Hep2 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human Hep2 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay	[PMID: 28942112]
HepG2	IC₅₀	>10 μM Compound: 11	Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay	[PMID: 30496987]
HepG2	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay	[PMID: 28757067]
HepG2	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay	[PMID: 28942112]
MCF7	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay	[PMID: 28757067]
MCF7	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay	[PMID: 28942112]
NCI-H1650	IC₅₀	>10 μM Compound: 11	Cytotoxicity against human NCI-H1650 cells after 48 hrs by MTT assay Cytotoxicity against human NCI-H1650 cells after 48 hrs by MTT assay	[PMID: 30496987]
PC-3	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay	[PMID: 28757067]
PC-3	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human PC3 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human PC3 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay	[PMID: 28942112]
RKO	IC₅₀	>10 μM Compound: 11	Cytotoxicity against human RKO cells after 48 hrs by MTT assay Cytotoxicity against human RKO cells after 48 hrs by MTT assay	[PMID: 30496987]
RKO	IC₅₀	>50 μM Compound: 1	Cytotoxicity against human RKO cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human RKO cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay	[PMID: 28942112]
SK-OV-3	IC₅₀	>10 μM Compound: 11	Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay	[PMID: 30496987]

Chemical Information

CAS No. 23833-97-8
분자량 179.60
화학식 C₉H₆ClNO
SMILES

O=C1C=CNC2=C1C=CC(Cl)=C2
선적

Room temperature in continental US; may vary elsewhere.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (269 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Li X, et al. Auto-Induction Effect of Chloroxoquinoline on the Cytochrome P450 Enzymes of Rats Associated with CYP 3A and 1A. PLoS One. 2015 Sep 23;10(9):e0138875. [Content Brief]

[2]. Liu J, et al. [Chloroxoquinoline inhibits invasion in breast cancer via down-regulating Rho/Rho kinase signaling pathway]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 Dec 25;48(6):631-637. Chinese. [Content Brief]

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

견적 받기 해외재고보유

Other size

견적 받기

Amount: USD 0.00

Biological Activity
- 제품 설명
Chemical Information
순도&문서
References

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent:

상품명:
CAS No.:
Species:
Purity:
수량:

Chloroxoquinoline

All DNA/RNA Synthesis Isoforms

All Cytochrome P450 Isoforms

All ROCK Isoforms